Abstract
PurposeThe growth and increasing sophistication of the legal cannabis industry necessitates further scientific inquiry to establish an evidence-based policy path forward. However, policymakers must balance public demand for cannabis reform with the lack of scientific consensus on key issues. This Commentary discusses Massachusetts’ statutory provisions supporting cannabis research, advances in social equity driven by data, and critical policy issues, which invite questions without clear scientific answers. FindingsAlthough the full breadth of inquiry needed cannot possibly be contained in a single article, this Commentary poses questions in 2 pertinent issue areas that affect adult and medical use. First, we discuss the current limitations on determining the scope and severity of cannabis-impaired driving and detecting impairment at any one point in time. Although experimental studies have found varying levels of impairment on driving ability, observational data have been inconclusive regarding the extent of traffic incidents involving cannabis impairment. A precise threshold for impairment and manner of detection must be established to develop just enforcement measures. Second, we discuss the lack of clinical standardization in medical cannabis use. In the absence of a consistent clinical framework, medical cannabis patients face undue burdens that limit access to treatment. A more well-defined clinical structure is needed to enhance use of and access to therapeutic cannabis treatment models. ImplicationsCannabis policy reform has gone forward at the will of voters despite the status of cannabis as a Schedule I controlled substance at the federal level, which has limited opportunities to research cannabis because it is commercially available. The implication of such limitations is realized by states leading cannabis reform, where unanswered questions present an opportunity for the scientific community to inform an evidence-based path forward in cannabis policy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.